These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7562251)
1. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material. Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251 [TBL] [Abstract][Full Text] [Related]
2. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
3. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Varley JM; Brammar WJ; Lane DP; Swallow JE; Dolan C; Walker RA Oncogene; 1991 Mar; 6(3):413-21. PubMed ID: 2011397 [TBL] [Abstract][Full Text] [Related]
4. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120 [TBL] [Abstract][Full Text] [Related]
5. p53 mutations and histological type of invasive breast carcinoma. Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152 [TBL] [Abstract][Full Text] [Related]
7. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas. Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192 [TBL] [Abstract][Full Text] [Related]
8. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033 [TBL] [Abstract][Full Text] [Related]
9. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma. McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210 [TBL] [Abstract][Full Text] [Related]
10. The role of p53 mutations in bilateral breast carcinoma. Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647 [TBL] [Abstract][Full Text] [Related]
11. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Thorlacius S; Börresen AL; Eyfjörd JE Cancer Res; 1993 Apr; 53(7):1637-41. PubMed ID: 8453635 [TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity and p53 gene mutations in breast cancer. Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488 [TBL] [Abstract][Full Text] [Related]
13. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037 [TBL] [Abstract][Full Text] [Related]
14. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers. Pollett A; Bedard YC; Li SQ; Rohan T; Kandel R Mod Pathol; 2000 Nov; 13(11):1173-9. PubMed ID: 11106073 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
16. p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Hurlimann J; Chaubert P; Benhattar J Mod Pathol; 1994 May; 7(4):423-8. PubMed ID: 8066070 [TBL] [Abstract][Full Text] [Related]
17. Mutations in the p53 gene occur in diverse human tumour types. Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845 [TBL] [Abstract][Full Text] [Related]
18. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781 [TBL] [Abstract][Full Text] [Related]
19. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP. Chen YH; Li CD; Yap EP; McGee JO J Pathol; 1995 Oct; 177(2):129-34. PubMed ID: 7490678 [TBL] [Abstract][Full Text] [Related]
20. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]